COMMUNIQUÉS West-GlobeNewswire

ProQR Doses First Patient in Phase 1/2 STELLAR Trial of QR-421a for Usher Syndrome Type 2

11/03/2019 - 13:00

LEIDEN, Netherlands and CAMBRIDGE, Mass., March 11, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the [...]

VBL Therapeutics to Present at the Society of Gynecologic Oncology (SGO) 50th Annual Meeting on Women's Cancer on March 18

11/03/2019 - 13:00

TEL AVIV, Israel, March 11, 2019 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]

Gritstone Oncology Announces the Appointment of Technology Executive, Mike Forcht, as Senior Vice President of Human Resources to Support Vision for Growth

11/03/2019 - 13:00

EMERYVILLE, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer [...]

Agile Therapeutics to Present at Upcoming Investor Conferences

11/03/2019 - 13:00

PRINCETON, N.J., March 11, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced today that its Senior Vice President and Chief Financial Officer, Scott Coiante will [...]

Eidos Therapeutics to Present at 31st Annual ROTH Conference

11/03/2019 - 13:00

SAN FRANCISCO, March 11, 2019 (GLOBE NEWSWIRE) -- Eidos Therapeutics , Inc. (Eidos) (Nasdaq:EIDX) today announced that management is scheduled to participate in a fireside chat regarding Eidos at the 31 st Annual ROTH [...]

MRI Interventions Announces Collaboration with Voyager Therapeutics for the Design, Manufacture and Supply of V-TAG™ Device

11/03/2019 - 13:00

IRVINE, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) a platform neurosurgery company developing products designed to deliver navigation, ablation, deep brain stimulation, aspiration, [...]

AlloSure Heart Clinical Validation Published in Leading Transplant Journal

11/03/2019 - 13:00

Alongside AlloSure Heart Validation, CareDx advances SHORE enrollment BRISBANE, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, [...]

Rubius Therapeutics Announces FDA Clearance of Investigational New Drug Application for First-Ever Red Cell Therapeutic, RTX-134, for Treatment of Phenylketonuria

11/03/2019 - 13:00

CAMBRIDGE, Mass., March 11, 2019 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biopharmaceutical company that is generating red blood cells and bioengineering them into an entirely new class of cellular [...]

Donnelly Group Confirms Plan for Cannabis Retail Chain, Hobo Recreational Cannabis Store

11/03/2019 - 13:00

Nine private recreational stores set to open nationwide beginning April 2019 VANCOUVER, British Columbia, March 11, 2019 (GLOBE NEWSWIRE) -- Donnelly Group, the Canadian hospitality company, today confirms its new [...]

aTyr Pharma Announces Research Collaboration With Global Biotherapeutics Leader CSL Behring

11/03/2019 - 13:00

Partnership to accelerate development of IND candidates from tRNA synthetases in aTyr’s pipeline aTyr eligible to receive up to $17 million in potential option fees SAN DIEGO, March 11, 2019 (GLOBE NEWSWIRE) -- aTyr [...]

Advantis Corp. Meeting With N2Pack to Expand Partnership

11/03/2019 - 13:00

NEWPORT BEACH, CA, March 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) announced a planned meeting with N2Pack’s executives at their corporate headquarters in Idaho. Advantis CEO [...]

UAHC Subsidiary American Sustainable Rubber Company, LLC Assigned Grant Funding from The Ohio State University “SEEDS” Program

11/03/2019 - 13:00

CHICAGO, March 11, 2019 (GLOBE NEWSWIRE) -- United American Healthcare Corporation (OTC: UAHC), an emerging technology holding company, today announced its wholly-owned subsidiary American Sustainable Rubber Company, [...]

Novan Completes End-of-Phase 2 Meeting and Provides Additional Business Updates

11/03/2019 - 13:00

Completed end-of-Phase 2 FDA meeting for molluscum contagiosum Meeting minutes received and support second quarter 2019 pivotal Phase 3 initiation Finalizing establishment of Irish entity to enable EU regulatory and [...]

Tauriga Sciences, Inc. Officially Launches its E-Commerce Site for the Sale of its CBD Infused Chewing Gum: Tauri-Gum

11/03/2019 - 13:00

Website: WWW.TAURIGUM.COM NEW YORK, NY, March 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG ) (“Tauriga” or the “Company”), engaged in building its business through the development [...]

Tyme Technologies To Present at the Oppenheimer 29th Annual Healthcare Conference on March 20, 2019

11/03/2019 - 13:00

NEW YORK, March 11, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME) , an emerging biotechnology company developing metabolic-based cancer therapies, announced that management will present a corporate [...]

Arch Therapeutics to Provide Corporate Update at the 31st Annual ROTH Conference

11/03/2019 - 12:50

FRAMINGHAM, Mass., March 11, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a [...]

Strongbridge Biopharma plc Announces Top-Line Results from Extended Evaluation Phase of the Pivotal Phase 3 SONICS Study of RECORLEV™ (levoketoconazole) for the Potential Treatment of Endogenous Cushing’s Syndrome

11/03/2019 - 12:30

~ Extended Evaluation Phase Meets Objective of Showing Positive Long-Term Benefit-Risk Profile of RECORLEV™ (levoketoconazole) ~ ~ Favorable Liver-Related Findings: No Patients Experienced an Increase in Either Alanine [...]

La Jolla Pharmaceutical Company Appoints Darryl Wellinghoff as Chief Commercial Officer

11/03/2019 - 12:30

SAN DIEGO, March 11, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve [...]

Marinus Pharmaceuticals Provides Business Update and 2018 Financial Results

11/03/2019 - 12:30

RADNOR, Pa., March 11, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric [...]